Revenue declined 4.7% year-over-year due to weakness in textiles and machinery, but real estate and dividend income supported stable operating and ordinary profit. Net income fell 7.1% amid impairment losses, and the company is restructuring its pharmaceutical business.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.